Market Place
Sourcing Support
Alterome Therapeutics names new CEO and Board of Director
10 Apr 2025 //
BUSINESSWIRE
Alterome Doses First Patient In Ph1 ALTA3263 (Pan-KRAS Inhibitor)
10 Mar 2025 //
BUSINESSWIRE
Alterome Doses 1st Patient in Ph 1 Study for AKT1 Mutant Tumors
30 Oct 2024 //
BUSINESSWIRE
Alterome Presents Preclinical Data for ALTA3263 at ENA Symposium
25 Oct 2024 //
BUSINESSWIRE
Alterome CEO Eric Murphy Named Top 100 Entrepreneur By Goldman Sachs
17 Oct 2024 //
BUSINESSWIRE
Alterome Presents Pre-Clinical Data Supporting the Development of Lead Program
08 Apr 2024 //
BUSINESSWIRE
Alterome raises $132M to take next-gen cancer drugs aimed at the `undruggable`
03 Apr 2024 //
ENDPTS
Alterome Establishes Advisory Board Comprised of Renowned Oncology Experts
05 Jan 2023 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.